Welcome to our dedicated page for Mistras SEC filings (Ticker: MG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The MISTRAS Group, Inc. (NYSE: MG) SEC filings page provides access to the company’s official U.S. Securities and Exchange Commission disclosures, which document its activities as a global provider of technology-enabled industrial asset integrity and testing solutions. Through these filings, investors can review how MISTRAS reports on its financial condition, operating performance, and use of non-GAAP measures such as Adjusted EBITDA, free cash flow, net debt, and income or operating income before special items.
Current reports on Form 8-K, for example, are used by MISTRAS to announce quarterly financial results and to describe the non-GAAP metrics it uses internally to evaluate performance and liquidity. These filings explain why management relies on measures like Adjusted EBITDA and free cash flow, how they are reconciled to the most comparable GAAP figures, and how they are applied in planning, forecasting, and incentive compensation. Other 8-K filings may cover matters such as equity awards to senior officers and related compensation arrangements.
In addition to 8-Ks, investors typically look to annual reports on Form 10-K and quarterly reports on Form 10-Q for more detailed information about segment performance across North America, International, and Products and Systems, as well as risk factors, debt levels, and cash flow. Proxy statements on Schedule 14A and related documents can provide further context on governance and executive compensation, while Forms 3, 4, and 5, when filed, disclose insider holdings and transactions in MG stock.
On Stock Titan, MISTRAS filings are paired with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand the main drivers behind reported results, changes in non-GAAP metrics, and other material disclosures. Real-time updates from EDGAR, combined with simplified explanations, make it easier to track how MISTRAS communicates its financial and operational position through its SEC reporting.
Natalia Shuman-Fabbri, President and CEO and Director of Mistras Group, Inc. (MG), reported awards on 09/08/2025. The filing shows receipt of 25,000 restricted stock units that vest 100% on the first anniversary of the grant and 35,000 stock options granted with a $9.71 exercise price, exercisable beginning 09/08/2026 and expiring 09/07/2035. Following the transactions she beneficially owns 25,000 shares from the RSUs and 35,000 underlying shares from the options, all held in a direct ownership form. The form was signed by an attorney-in-fact on 09/09/2025.
Mistras Group granted equity awards to its CEO to align her interests with shareholders. On September 8, 2025, the Compensation Committee awarded Natalia Shuman 25,000 restricted stock units (RSUs) and options to purchase 35,000 shares. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant and convert one-for-one into common stock upon vesting. The options have an exercise price of $9.71 (the September 8, 2025 NYSE closing price), become exercisable on or after September 8, 2026, and expire 10 years after the grant date, subject to standard exceptions for termination, death, or disability.
The committee noted Ms. Shuman received no equity at hire and that these awards follow eight months in her role. The Option Agreement and RSU Agreement are filed as exhibits.
Mistras Group, Inc. reported total revenue of $185.4 million for the quarter ended June 30, 2025, down from $189.8 million a year earlier, reflecting a 2.3% decline driven primarily by lower North America oil & gas activity and voluntary laboratory consolidations. Gross profit rose to $53.9 million from $51.3 million, lifting gross margin to 29.1% from 27.1%, while operating income fell to $8.4 million from $12.0 million. The company recorded net income of $3.1 million for the quarter; for the six months the company reported a small net loss of $42 thousand versus net income of $7.4 million in the prior year.
Total assets increased to $571.0 million and accounts receivable rose to $159.8 million, with unbilled revenue of $41.0 million at June 30, 2025. Debt outstanding totaled $189.4 million, and the company drew on its revolver during the period; management states it remains in compliance with its credit covenants and believes it can meet liquidity needs. The filing discloses an active environmental lawsuit in Arizona related to a Phoenix testing facility; remediation costs and penalties are considered probable but not yet estimable, representing a material uncertainty.